Simvastatin

Chemical formula: C₂₅H₃₈O₅  Molecular mass: 418.566 g/mol  PubChem compound: 54454

Therapeutic indications

Simvastatin is indicated for:

Primary hypercholesterolemia, mixed dyslipidaemia

Population group: only adults (18 years old or older)

Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cardiovascular prevention

Population group: only adults (18 years old or older)

Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Homozygous familial hypercholesterolaemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid-lowering treatments (e.g. LDL-apheresis) or if such treatments are not appropriate.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Simvastatin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Disorder of liver

Hepatopathy

Potent CYP3A4 inhibitors

Strong CYP3A4 inhibitors

Lomitapide with doses >40 mg simvastatin in patients with homozygous familial hypercholesterolaemia

Lomitapide

Ciclosporin

Ciclosporin

Danazol

Danazol

Gemfibrozil

Gemfibrozil

Fusidic acid

Fusidic acid

Major medical or surgical condition

Surgical procedure

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.